Safety and efficacy profile of ozenoxacin 1% cream in pediatric patients with impetigo
| Autor: | Xavier Masramon, Adelaide A. Hebert, Núria Albareda López, Ilonka Zsolt, Theodore Rosen |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Retapamulin
medicine.medical_specialty Impetigo Topical antibiotics Dermatology Clinical success Pediatrics Article 030207 dermatology & venereal diseases 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Ozenoxacin medicine skin and connective tissue diseases business.industry Antibiotic Pediatric age medicine.disease chemistry Topical 030220 oncology & carcinogenesis RL1-803 Safety business |
| Zdroj: | International Journal of Women's Dermatology, Vol 6, Iss 2, Pp 109-115 (2020) International Journal of Women's Dermatology |
| ISSN: | 2352-6475 |
| Popis: | Background: Ozenoxacin is a topical antibiotic approved in the United States for treatment of impetigo in adults and children age ≥2 months. This analysis evaluated the efficacy and safety of ozenoxacin in specific pediatric age groups. Methods: Data for children aged 2 months to |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|